![]() |
|
|
Unité Nutrition, Laboratoire Génie Biologique et Sciences des Aliments, Université Montpellier II, 34095 Montpellier, France and * Group of Bio-inorganic Analytical Chemistry, CNRS-UMR 5034, Hélioparc, 64053 Pau, France
2To whom correspondence should be addressed. E-mail: rouanet{at}arpb.univ-montp2.fr.
| ABSTRACT |
|---|
|
|
|---|
18%), with the majority
present in the form of two selenoproteins (2030 kDa and 80 kDa).
Gross absorption of Se from SeSp was significantly lower than from free
SeMet and sodium selenite. SeMet was less effective than sodium
selenite in restoring Se concentration in the liver but not in kidney.
SeSp was always much less effective. Similarly, Se from SeSp was less
effective than the other forms of Se in restoring GSH-Px activity,
except in plasma and red blood cells where no differences were noted
among the three sources. This was confirmed by measuring the
bioavailability of Se by slope-ratio analysis using selenite as the
reference form of Se. Although Se from SeSp did not replenish Se
concentration and GSH-Px activity in most tissues to the same
degree as the other forms of Se, we conclude that it is biologically
useful and differently metabolized due to its chemical form.
KEY WORDS: selenium Spirulina rats glutathione peroxidase
| INTRODUCTION |
|---|
|
|
|---|
The major forms of selenium occurring in foodstuffs are the organic,
protein-associated forms, selenomethionine (SeMet, plant and animal
sources) and selenocysteine (SeCys, animal sources). Selenate is also
present in some foodstuffs (16)
, and in
selenium-deficient areas, inorganic selenium salts (selenite,
selenate) are added to the food (17)
. The activity of
selenoproteins depends on an adequate selenium supply from the diet.
Because Se enters the food chain through plants, its availability may
vary with climatic and soil fertilization conditions. Moreover, Se in
foodstuffs is not always available for intestinal absorption, and there
are differences both between and within species (18
19
20
21)
.
The metabolism of selenium varies according to the form of selenium
ingested. It was demonstrated (22)
that SeMet and selenate
are more diffusible than selenocysteine and selenite under simulated
gastrointestinal conditions, contributing to their high absorption in
vivo. Moreover, reutilization of organic selenium is one of the most
important differences in the metabolism of SeMet and selenite
(23)
.
It is very important to know the bioavailability of selenium present in
the diet to establish nutritional Se status in relation to dietary
intake and to intervene promptly in cases of Se deficiency. In the
present study, we examined the bioavailability of Se from SeMet, sodium
selenite (Na2SeO3) and from
enriched Spirulina platensis, a blue-green alga which is
commercially available for human consumption, and now used as a health
food source of Se for humans (24)
. We reported previously
that Spirulina grown in the presence of selenium showed health benefits
in rats fed high cholesterol diets (25)
. The ability to
control its chemical composition by varying cultivation conditions
makes Spirulina a vegetable that can easily be enriched with Se by way
of the aquatic medium. This work investigated the ability of
Se-enriched Spirulina (SeSp) to provide biologically available Se
to rats. Experiments using Se-deficient rats were conducted to
measure tissue uptake of the element and GSH-Px activity.
| MATERIALS AND METHODS |
|---|
|
|
|---|
This step was performed at Aquamer S.A. (Mèze, France). Algae (Spirulina platensis) were grown in a 130-L photobioreactor under continuous lighting on Zarouks medium at 22°C and pH 10.5 in the presence of SeO2. This medium contained NaHCO3, 16.8 g/L; K2HPO4, 0.5 g/L; NaNO3, 2.5 g/L; K2SO4, 1.0 g/L; NaCl, 1.0 g/L; MgSO4 · 7H2O, 0.2 g/L; CaCl2, 0.04 g/L; FeSO4 · 7H2O, 0.01 g/L; EDTA, 0.08 g/L; H3BO3, 2.86 mg/L; MnCl2 · 4H2O, 1.81 mg/L; ZnSO4 · 7H2O, 220 µg/L; CuSO4 · 5H2O, 79 µg/L; MoO3, 15 µg/L; and Na2MoO4, 21 µg/L and was supplied with light aeration (30 L/min) and the addition of 0.03% CO2. At the end of the growth, the biomass was recovered and filtered through a 20-µm membrane, thoroughly washed with distilled water, frozen and lyophilized.
Characterization of selenium speciation in fortified Spirulina.
Selenium speciation was characterized by a sequential extraction with
reagent solutions designed to selectively leach different classes of
selenium species into an aqueous phase. The latter was subsequently
characterized by size exclusion HPLC with Se-specific detection by
inductively coupled plasma mass spectrometry (ICP-MS)
(26)
. A 0.2-g sample was taken for analysis. It was
extracted sequentially as follows: 1) 5 mL of hot water
(8590°C) by agitation for 1 h for water-soluble
selenospecies; 2) 5 mL of 4% Driselase in 30 mmol/L
Tris-HCl buffer (pH 7.0) in the presence of 1 mmol/L
phenylmethylsulfonyl fluoride by agitation for 1 h at 25°C for
selenium associated with cell wall; 3) 5 mL of 30 mmol/L
Tris-HCl buffer (pH 7.0) containing 4% SDS by agitation for 1 h at 25°C for water-insoluble selenoproteins; and
4) 5 mL of phosphate buffer (pH 7.5) by incubation for
16 h at 37°C with a mixture containing 20 mg of Pronase and 10
mg of lipase to break the residual selenoproteins. Selenium was
determined by ICP-MS in the supernatant remaining after the
centrifugation. The final residue was dissolved completely in 2 mL of
250 g/L tetramethylammonium hydroxide in water to determine the
residual Se. A 100-µL aliquot of extract (10-fold
diluted) was injected on a Superdex Peptide HR 10/30 column (Pharmacia,
Uppsala, Sweden) and eluted at 0.75 mL/min with 30 mmol/L Tris-HCl
buffer (pH 7.5). 78Se, 80Se and
82Se were monitored on-line using an ELAN 6000 ICP MS
spectrometer (PE-SCIEX, Thornhill, Canada).
Animals and diets.
Male Sprague-Dawley rats (Iffa Credo, LArbresle, France) weighing
68 g were used. Rats were housed individually in
stainless steel metabolic cages and had free access to deionized water.
They were kept under light from 0700 to 1900 h, and the room
temperature was 23 ± 1°C, with constant humidity. Rats were fed
a Torula yeast (TY)-based selenium-deficient diet throughout the
98-d experiment (Table 1
). They were maintained by pair-feeding to the food intake of the
group with the lowest intake over the experimental periods, i.e., each
group received daily a quantity of food equal to that eaten by this
group the day before. Rats were weighed weekly. On arrival and just
before the beginning of the experimental period, five rats were
selected at random and killed to establish baseline values for tissue
GSH-Px activity and Se concentration. At the start of the
experiment, rats (n = 70) were divided into two dietary
groups on the basis of average body weight. The control group
(n = 20) received the TY diet to which was added 75
µg Se/kg as
Na2SeO3. This suboptimal
level was chosen to generate nonplateauing GSH-Px activities
(27)
. In fact, the use of the optimal Se level (100
µg/kg) most likely would prevent detection of any
metabolic differences that might have been detected with a level lower
than the dietary Se requirement. The remaining rats (n
= 50) were fed the TY Se-deficient basal diet (Se-deficient
dietary group) which contained 7 µg Se/kg. After 42 d, five rats from each group were anesthetized by an intraperitoneal
injection of pentobarbital, and tissues (liver, kidney and blood) were
removed for Se bioassays and GSH-Px activity to ascertain that the
Se-deficient diet had depleted Se. The repletion period lasted from
d 43 to 98. The rats from the Se-deficient group were randomly
divided into three groups of 15 and fed diets containing 75
µg Se/kg as
Na2SeO3, SeMet or SeSp.
Five rats of each group were killed at d 7, 28 and 56 of the repletion
period. Five animals from the control group were also killed at the
same times.
|
Rats were handled according to NIH guidelines (28)
. They
were deprived of food overnight and anesthetized with pentobarbital (60
g/L pentobarbital , 60 mg/kg body) before tissues were excised. The
liver was perfused with 0.15 mol/L KCl to remove residual blood,
rapidly excised, rinsed in ice-cold saline, blotted dry, weighed,
sectioned for analyses and stored in liquid nitrogen. Kidneys were also
removed, washed in ice-cold saline, blotted, weighed and frozen
immediately in liquid nitrogen.
Liver and kidney were homogenized in 5 volumes of ice-cold 0.1
mol/L potassium phosphate buffer (pH 7.4), and the homogenate was
centrifuged at 13000 x g for 15 min at 4°C. The
supernatant was then centrifuged at 105000 x g for
60 min at 4°C and the cytosol was stored at -80°C for subsequent
assay of GSH-Px activity. Glutathione peroxidase activity was
measured by the method of Wendel (29)
using 0.2 mmol/L
hydrogen peroxide as the substrate and including 1.0 mmol/L sodium
azide to inhibit catalase; thus, only Se-dependent GSH-Px activity
was measured. The cytosolic protein content was determined by a
commercial protein assay (Sigma, Saint Quentin Fallavier, France)
according to Smith et al. (30)
and using bovine serum
albumin as the standard.
Blood was withdrawn by cardiac puncture and aliquots were transferred to heparinized tubes, then centrifuged at 1000 x g for 10 min to separate plasma and erythrocytes. The erythrocytes obtained were washed with saline and hemolyzed in 9 volumes of hypotonic buffer (5 mmol/L sodium phosphate buffer, pH 7.0).
Feces were collected from each rat during the last 5 d of the repletion period for intestinal absorption measurements.
Selenium was analyzed by ICP-MS after samples were digested in nitric acid and hydrogen peroxide.
Assessment of Se bioavailability.
The bioavailability of Se from sodium selenite, SeMet and SeSp was assessed by using sodium selenitefed control rats as the reference. The deposition of Se and the increase in GSH-Px activity in different tissues were used as the responses to time of repletion (T). Because this response R can be described by the equation, R = mT + k, the relative bioavailability of Se from the three sources was estimated by the slope-ratio technique, which compares the slope of the time-response plots observed for SeMet and SeSp to that observed for sodium selenite.
Statistical analyses.
Data are shown as the means ± SEM, n = 5. Data were subjected to logarithmic transformation where necessary to achieve homogeneity of variances. Statistical analyses of data were performed by one-way ANOVA followed by Fishers Protected Least Significant Difference post-hoc procedure using a StatView 512 + microcomputer program (Brain Power, Calabasas, CA). Differences were considered significant when P < 0.05.
| RESULTS |
|---|
|
|
|---|
10% of the water-soluble Se (2%
of total Se), indicating that algae had metabolized the
SeO2 from the culture medium. Most of the
water-soluble selenium was present as a macromolecule of 6080
kDa. The attack with Driselase (an enzyme preparation containing
laminarinase, xylanase and cellulase) liberated an additional 18% of
Se (bound to cell walls) that eluted at the elution volume of
selenomethionine. The majority of Se in Spirulina (40%) was present in
the form of selenoproteins, which can be solubilized by a solution of
SDS. Figure 1
12% present in the form of a macromolecular
compound but also Se(IV) and selenomethionine. The remaining 7% of
selenium was resistant to the above reagents.
|
|
|
|
|
|
|
|
|
100% except kidney Se (SeMet) and plasma
GSH-Px (SeSp). These data confirm those in Tables 3
|
|
| DISCUSSION |
|---|
|
|
|---|
Selenium consumed in foods and supplements exists in a number of
organic and inorganic forms, including selenomethionine (plant and
animal sources and supplements), selenocysteine (SeCys) (mainly animal
sources), selenite and selenate (mainly supplements). Bioavailability
and tissue distribution depend on the form ingested. For instance,
SeMet is more effective in increasing Se status because it is
nonspecifically incorporated into proteins in place of methionine
(34)
. It must, however, be catabolized to an inorganic
precursor before entering the available Se pool. Selenite is a more
available metabolic source of Se than SeMet because it needs only to be
reduced to selenide to provide selenophosphate, the precursor of SeCys,
which is the active form of Se in selenoproteins (35)
.
Despite this, organic forms are often preferred in interventions,
partly because they are less acutely toxic (36)
. However,
the supplemental form of Se should not accumulate excessively in the
body. This work shows that SeSp meets this criterion for a good
supplemental form of Se because it does not replenish the Se pool to
the same extent as sodium selenite, for example, and consequently it
does not accumulate in the tissues studied (kidney, liver). It must be
pointed out that SeMet as well as selenoproteins from Spirulina must be
digested for intestinal absorption and subsequent metabolism; selenite
does not. The blue green algae Spirulina belongs to the cyanobacteria
family; in this regard, it is closely related to bacteria, in which the
Se metabolism incorporates SeCys into proteins; such a process also
occurs in mammals (37)
. Elsewhere, we could
consider that these microalgae belong too to the plant kingdom. This
dual-property makes spirulina an ubiquitous material which could
contain Se into forms identical to SeMet (plant and animal sources) and
SeCys (animal sources) and probably other metabolites. In fact,
selenium speciation in Spirulina seems to be distinctly different from
that in selenized yeast and allium plants. Moreover, low-molecular-mass
compounds (amino acids and oligopeptides), which account for the
majority of Se in yeast and garlic (38)
, are present only
in small amounts in the microalgae investigated. Few previous studies
feeding rats Se as high selenium garlic (in the form of
seleno-methyl selenocysteine) (39)
and high selenium
broccoli (40)
, in the same chemical form as in garlic
(41)
, reported that these organic forms of Se tended to
incorporate less into most tissues than Se fed as SeMet. Our results
are consistent with such findings, although Isp and Lisk
(39)
fed 3 mg Se/kg diet and Finley (40)
refed rats with 100 µg Se/kg diet for 63 d vs. 75
µg Se/kg diet for 56 d in our study. Moreover, Finley
used L-SeMet, whereas we chose
DL-SeMet. The lower dietary Se level (75
µg/kg diet) and reduced intestinal absorption of Se from
SeSp could in part explain our results. Moreover, several forms of Se
were present in these algae; SeMet accounted for a small part of Se,
the majority of which was linked to cell walls and therefore not
readily available to the body. It is likely that the effects observed
were to a great extent due to the proteins detected (2030 kDa and 80
kDa).
Although kidney is the tissue in which Se is most concentrated
(42)
, GSH-Px activity predominates in the liver
(43)
. This difference would suggest that renal Se is used
in activities other than GSH-Px activity. Selenium-dependent
glutathione peroxidase and phospholipid hydroperoxide glutathione
peroxidase have been shown to be very active in renal membranes
(44)
. The selenoprotein type I iodothyronine
5'-nucleotidase is localized on the cytosolic surface of the renal cell
basolateral plasma membrane (45)
; the plasma GSH-Px
(i.e., GSH-Pxec) is synthesized mainly in the
proximal renal tubules and appears to be secreted through the tubule
basolateral membrane (46)
. Because kidney is the site of
synthesis for these selenoproteins, this could explain in part the high
uptake of Se by this tissue and its need for a reserve at a site in
which Se accumulation is not toxic for cells (47)
. Thus,
kidney could serve as a storage site before the release of seleniated
molecules into the bloodstream or as Se reserve for the body after
glomerular filtration and reabsorption. Although Se from SeSp was the
least effective in restoring kidney Se concentration and GSH-Px
activity, the similar plasma GSH-Pxec activities
obtained for all of the treatment groups after 56 d would suggest
that this Se source is able to supply sufficient Se for this purpose
and explain why renal Se is used in other activities than GSH-Px, a
protein relatively low in the hierarchy of Se use.
In this study we reported that Se from SeSp was less effective than
organic and inorganic supplements in restoring GSH-Px activity and
Se concentrations in several tissues and organs of Se-depleted
rats. Plasma and erythrocyte GSH-Px activities were exceptions
because no effect of a particular chemical form was observed, as has
been reported (48)
. However, it must be pointed out that
for each tissue studied, GSH-Px activity increased after refeeding
with SeSp, although the increase was not as rapid as with other
sources. Thus, Se from SeSp is less bioavailable than selenite and
SeMet. As clearly stated by Finley et al. (49)
,
bioavailability can be used synonymously with biological usefulness.
Therefore, Se-enriched Spirulina represents a useful source of
selenium.
This work was devoted to Se bioavailability from Spirulina; to our
knowledge, it is the first study relative to this microalgae and
contributes novel data concerning this potentially beneficial Se
supplement. The primary public impetus for Se supplementation is the
potential benefit for reduction of cancer. Ip and co-workers
(39
,50
51
52)
as well as the study by Finley et al.
(49)
of colon cancer and high selenium broccoli
demonstrated that cancer reduction is not a function of tissue selenium
concentrations or GSH-Px activities and that the least bioavailable
Se compounds may exhibit potent biological activities. Thus, the
anticancer effect of a Se-containing compound may be more closely
related to its ability to produce antitumorigenic metabolites, such as
methyl selenol (52)
. It is very important, therefore, to
define more precisely the forms of Se present in Se-Spirulina to
permit identification of the most active anticarcinogenic component(s)
and to recommend such a source as a Se supplement. Before such a study
can be conducted, due to the several forms of selenium in Spirulina,
fractionation of the algae is in progress currently to identify more
clearly the chemical forms of Se in the issuing fractions.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
3 Abbreviations used: GSH-Px, glutathione
peroxidase; GSH-Pxec, extracellular GSH-Px; ICP-MS,
inductively coupled plasma mass spectrometry; SeSp, Se-enriched
Spirulina; TY, Torula yeast. ![]()
Manuscript received January 29, 2001. Initial review completed February 20, 2001. Revision accepted May 23, 2001.
| LITERATURE CITED |
|---|
|
|
|---|
1. Schwarz K. & Foltz C. M. (1957) Selenium as an integral part of factor 3 against dietary necrotic liver degeneration. J. Am. Chem. Soc. 79:3292-3293.
2. You-Ping Z. & Combs G. F., Jr (1984) Effect of dietary protein level and level of food intake on the apparent bioavailability of selenium for the chick. Poult. Sci. 63:294-303.[Medline]
3. Brätter P., Negretti S., Rösick U. & Stockhausen H. B. (1984) Development of selenium deficiency in the total parenteral nutrition of infants. Combs G. F., Jr Spallholz J. E. Levander O. A. eds. Proceedings of the Third International Symposium on Selenium in Biology and Medicine 1984:652-656 AVI New York, NY. .
4. Burk R. F. & Hill K. E. (1993) Regulation of selenoproteins. Annu. Rev. Nutr. 13:65-81.[Medline]
5. Behne D., Weiss-Nowak C., Kalcklösch M., Westphal C., Gessner H. & Kyriakopoulos A. (1995) Studies on the distribution and characteristics of new mammalian selenium-containing proteins. Analyst 120:823-825.[Medline]
6. Burk R. F. (1990) Protection against free radical injury by selenoenzymes. Pharmacol. Ther. 45:383-385.[Medline]
7. Keshan Disease Research Group of the Chinese Academy of Medical Science, Beijing (1979) Epidemiologic studies on the etiologic relationship of selenium and Keshan disease. Chin. Med. J. 92:477-482.[Medline]
8. Chen A., Yang F., Chen J., Chen X., Wen Z. & Ge K. (1980) Studies on the relation of selenium and Keshan disease. Biol. Trace Elem. Res. 2:91-107.
9. Shamberger R. J., Willis C. E. & McCormack L. J. (1978) Selenium and heart disease. III. Blood selenium and heart mortality in 19 states. Hemphill D. D. eds. Trace Substances in Environmental Health 12:59-63 University of Missouri Press Columbia, MO .
10. Schrauzer G. N., White D. A. & Schneider C. J. (1977) Cancer mortality correlation studies. III. Statistical associations with dietary selenium intakes. Bioinorg. Chem. 7:23-34.[Medline]
11.
Salonen J. T., Alfthan G., Huttunen J. K. & Puska P. (1984) Association between selenium status and the risk of cancer. Am. J. Epidemiol. 120:342-349.
12. Tarp U., Overvad K., Hansen J. C. & Thorling E. B. (1985) Low selenium level in severe rheumatoid arthritis. Scand. J. Rheumatol. 14:97-101.[Medline]
13. Fecondo J. V. & Augusteyn R. C. (1983) Superoxide dismutase, catalase and glutathione peroxidase in the human cataractous lens. Exp. Eye Res. 36:15-23.[Medline]
14. Levander O. A. (1984) The importance of selenium in total parenteral nutrition. Bull. N.Y. Acad. Med. 60:144-155.[Medline]
15. Von Stockhausen H. B. (1988) Selenium in total parenteral nutrition. Biol. Trace Elem. Res. 15:147-155.[Medline]
16. Olson O. E. & Palmer S. (1978) Selenium in food consumed by South Dakotans. Proc. S.D. Acad. Sci. 57:113-121.
17. Van Vleet J. F. (1980) Current knowledge of selenium-vitamin E deficiency in domestic animals. J. Am. Vet. Med. Assoc. 176:321-325.[Medline]
18. Gabrielsen J. O. & Opstevedt J. (1980) Availability of selenium in fish meal in comparison with soybean meal, corn gluten meal and selenomethionine relative to selenium in sodium selenite for restoring glutathione peroxidase activity in selenium-depleted chicks. J. Nutr. 110:1096-1100.
19. Douglass J. S., Morris V. C., Soares J. H. & Levander O. A. (1981) Nutritional availability to rats of selenium in tuna, beef kidney, and wheat. J. Nutr. 111:2180-2187.
20. Ringdal O., Bjornestad E. O. & Julshamn K. (1985) Comparative utilization of fish selenium and inorganic selenite by rats of normal selenium status. Ann. Nutr. Metab. 29:297-305.[Medline]
21. Wen H. Y., Davis R. L., Shi B., Chen J.-J., Chen L., Boylan M. & Spallholz J. E. (1997) Bioavailability of selenium from veal, chicken, beef, pork, lamb, flounder, tuna, selenomethionine, and sodium selenite assessed in selenium-deficient rats. Biol. Trace Elem. Res. 58:43-53.[Medline]
22. Schen L., Van Dyck K., Luten J. & Deelstra H. (1997) Diffusibility of selenate, selenite, seleno-methionine, and seleno-cystine during simulated gastrointestinal digestion. Biol. Trace Elem. Res. 58:55-63.[Medline]
23.
Swanson C. A., Patterson B. H., Levander O. A., Veillon C., Taylor P. R., Helzlsouer K., McAdam P. A. & Zech L. A. (1991) Human [74Se]selenomethionine metabolism: a kinetic model. Am. J. Clin. Nutr. 54:917-926.
24. Kay R. A. (1991) Microalgae as food and supplement. Crit. Rev. Food Sci. Nutr. 30:555-573.[Medline]
25. Cases J., Puig M., Caporiccio B., Baroux B., Baccou J. C., Besançon P. & Rouanet J. M. (1999) Glutathione related enzymic activities in rats receiving high cholesterol or standard diets supplemented with two forms of selenium. Food Chem 65:207-211.
26. Casiot C., Szpunar J., Lobinski R. & Potin-Gautier M. (1999) Sample preparation and HPLC separation approaches to speciation analysis of selenium in yeast by ICP MS. J. Anal. At. Spectrom. 14:645-650.
27. Weiss S. L., Evenson J. K., Thompson K. M. & Sunde R. A. (1997) Dietary selenium regulation of glutathione peroxidase mRNA and other selenium-dependent parameters in male rats. J. Nutr. Biochem. 8:85-91.
28. National Research Council (1985) Guide for the Care and the Use of Laboratory Animals. Publication no. 8523 (rev.) 1985 National Institutes of Health Bethesda, MD .
29. Wendel A. (1981) Glutathione peroxidase. Methods Enzymol 77:325-333.[Medline]
30. Smith S. K., Krohn R. I., Mallia A. K., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J. & Klenk D. K. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85.[Medline]
31. Combs G. F., Jr & Combs S. B. (1986) The biological availability of selenium in foods and feeds. Combs G. F., Jr Combs S. B. eds. The Role of Selenium in Nutrition 1986:127-177 Academic Press New York, NY. .
32. Shi B. S. & Spallholz J. E. (1994) Selenium from beef is highly bioavailable as assessed by liver glutathione peroxidase (EC 1.11.1.9) activity and tissue selenium. Br. J. Nutr 72:873-881.[Medline]
33. Behne D. & Wolters W. (1983) Distribution of selenium and glutathione peroxidase in the rat. J. Nutr. 113:456-461.
34. Thomson C. D., Robinson M. F., Butler J. A. & Whanger P. D. (1993) Long-term supplementation with selenate and selenomethionine: selenium and glutathione peroxidase (EC 1.11.1.9) in blood components of New Zealand women. Br. J. Nutr 69:577-588.[Medline]
35. Allan C. B., Lacourciere G. M. & Stadtman T. C. (1999) Responsiveness of selenoproteins to dietary selenium. Annu. Rev. Nutr. 19:1-16.[Medline]
36. Standing Committee of the Scientific Evaluation of Dietary Reference Intakes of the Food and Nutrition Board, Institute of Medicine, the National Academies with Health Canada (2000) Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids 2000 National Academy Press Washington, DC. .
37. Böck A. (1993) Incorporation of selenium into bacterial selenoproteins. Burk R. F. eds. Selenium in Biology and Human Health 1993:9-24 Springer-Verlag New York, NY. .
38. Lobinski R., Edmonds J., Suzuki K. & Uden P. C. (2000) Species-selective determination of selenium compounds in biological materials. Pure Appl. Chem 72:447-461.
39.
Ip C. & Lisk D. J. (1994) Characterization of tissue selenium profiles and anticarcinogenic responses in rats fed natural sources of selenium-rich products. Carcinogenesis 15:573-576.
40. Finley J. W. (1998) The absorption and tissue distribution of selenium from high-selenium broccoli are different from selenium from sodium selenite, sodium selenate, and selenomethionine as determined in selenium-deficient rats. J. Agric. Food Chem. 46:3702-3707.
41. Cai X.-J., Block E., Uden P. C., Zhang X., Quimby B. D. & Sullivan J. J. (1995) Allium chemistry: identification of selenoamino acids in ordinary and selenium-enriched garlic, onion, and broccoli using gas chromatography with atomic emission detection. J. Agric. Food Chem 43:1754-1757.
42. Beilstein M. A. & Whanger P. D. (1985) Selenium accumulation tissues, tissue fractions and cytosolic proteins in rats. Biochem. Arch. 1:153-162.
43. Hawkes W. C., Wilhelmsen E. C. & Tappel A. L. (1985) Abundance and tissue distribution of selenocysteine-containing proteins in the rat. J. Inorg. Biochem. 23:77-92.[Medline]
44. Zhang L., Maiorino M., Roveri A. & Ursini F. (1989) Phospholipid hydroperoxide glutathione peroxidase: specific activity in tissues of rats of different age and comparison with other glutathione peroxidases. Biochim. Biophys. Acta 1006:140-143.[Medline]
45.
Leonard J. L., Ekenbarger D. M., Frank S. J., Farwell A. P. & Koehrle J. (1991) Localization of type I iodothyronine 5'-nucleotidase to the basolateral plasma membrane in renal cortical epithelial cells. J. Biol. Chem. 266:11262-11269.
46.
Avissar N., Ornt D. B., Yagil Y., Horowitz S., Watkins R. H., Kerl E. A., Takahashi K., Palmer I. S. & Cohen H. J. (1994) Human kidney proximal tubules are the main source of plasma glutathione peroxidase. Am. J. Physiol. 266:C367-C375.
47. Mony M.-C. & Larras-Regard E. (2000) Renal bioavailability of selenium after supplementation with different forms of selenium: ion probe and mass spectrometry study. J. Trace Elem. Exp. Med. 13:367-380.
48. Nève J. (1998) Bioavailability and safety of selenium supplements. Collery Ph Brätter P. Negretti de Brätter V. Khassanova L. Etienne J. C. eds. Metal Ions in Biology and Medicine 1998:242-247 John Libbey Eurotext Paris, France. .
49.
Finley J. W., Davis C. D. & Feng Y. (2000) Selenium from high selenium broccoli protects rats from colon cancer. J. Nutr. 130:2384-2389.
50. Ip C. & Lisk D. J. (1994) Enrichment of selenium in allium vegetables for cancer prevention. Carcinogenesis 9:1881-1885.
51.
Ip C. & Lisk D. J. (1995) Efficacy of cancer prevention by high-selenium garlic is primarily dependent on the action of selenium. Carcinogenesis 16:2649-2652.
52.
Ip C. & Ganther H. (1996) Activity of methylated forms of selenium in cancer prevention. Cancer Res 50:1206-1211.
This article has been cited by other articles:
![]() |
S. Jackson, M. Calos, A. Myers, and W. T. Self Analysis of Proline Reduction in the Nosocomial Pathogen Clostridium difficile J. Bacteriol., December 15, 2006; 188(24): 8487 - 8495. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Reeves, P. D. Leary, B. R. Gregoire, J. W. Finley, J. E. Lindlauf, and L. K. Johnson Selenium Bioavailability from Buckwheat Bran in Rats Fed a Modified AIN-93G Torula Yeast-Based Diet J. Nutr., November 1, 2005; 135(11): 2627 - 2633. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||